Xiaodong Wang, Director at BeOne Medicines, sold ONC on Sep 28, 2026
Data as of Oct 16
- Traded
- Sep 28, 2026
- Disclosed
- Sep 30, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ONC since disclosure
+0.9%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund
Change in closing price from Sep 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLXiaodong Wang DirectorONC BeOne Medicines Ltd.$43Kdisclosed Sep 30 · filed 2 days after the trade
- ▼ SELLXiaodong Wang DirectorONC BeOne Medicines Ltd.$57.1Kdisclosed Sep 30 · filed 2 days after the trade
- ▼ SELLXiaodong Wang DirectorONC BeOne Medicines Ltd.$1.5Mdisclosed Sep 30 · filed 2 days after the trade
- ▼ SELLXiaodong Wang DirectorONC BeOne Medicines Ltd.$749Kdisclosed Sep 30 · filed 2 days after the trade
- ▼ SELLXiaodong Wang DirectorONC BeOne Medicines Ltd.$1.3Mdisclosed Sep 30 · filed 2 days after the trade
- ▼ SELLXiaodong Wang DirectorONC BeOne Medicines Ltd.$5.3Mdisclosed Sep 30 · filed 2 days after the trade
- ▼ SELLXiaodong Wang DirectorONC BeOne Medicines Ltd.$809Kdisclosed Sep 30 · filed 2 days after the trade
- ▼ SELLXiaodong Wang DirectorONC BeOne Medicines Ltd.$1.2Mdisclosed Sep 30 · filed 2 days after the trade
- ▼ SELLXiaodong Wang DirectorONC BeOne Medicines Ltd.$14.4Kdisclosed Sep 30 · filed 2 days after the trade